(MENAFN- Baystreet) Spotify CEO Sells Company Stock As Share Price Doubles
Oracle Skids on Hiking AI Might
IBM To Expand Canadian Semiconductor Plant
Roper Tumbles on Q1 Results
Microsoft's Earnings Top Forecasts Driven By Cloud Growth Previous Articles Subscribe to Get Small Cap News & Alerts Baystreet Staff - Monday, April 29, 2024
Philips' Stock Rises 40% On News Of Respiratory Case Settlement The stock of Dutch medical device company Philips (PHG) is up more than 40% after the company agreed to pay $1.1 billion U.S. to settle personal injury cases in America related to its sleep apnea products.
Millions of Philips' sleep apnea devices were recalled in 2021 over concerns that components carried potential cancer risks. Class action lawsuits followed the company's recall.
Now, Philips says that the settlement it agreed to pay will end the uncertainty over the litigation for the company.
It said in a news release that it did not admit any fault or liability, or that any injuries were caused by its Respironics sleep apnea devices.
The $1.1 billion U.S. payment made by Philips is also less than the $4 billion U.S. that was expected by many analysts who cover the company and its stock.
Philips still faces some lawsuits in Europe over the sleep apnea recall. However, most of the legal cases are now considered settled.
The 40% jump in Philips stock on news of the legal settlement takes the company's share price to its highest level since March 2022.
Prior to today (April 29), Philips' stock had risen 6% over the past 12 months to trade at $21.07 U.S. per share. However, over five years, the stock is down 47%.
About Us Contact Us Advertise License Our Content Jobs Disclaimer Privacy Policy
Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks
MENAFN29042024000212011056ID1108151784
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.